Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
IsoPlexis
What Does IsoPlexis Do?
IsoPlexis Inc. was a life science technology company dedicated to accelerating the development of curative medicines by providing advanced solutions for single-cell functional proteomics. Their platforms, notably the IsoLight and IsoSpark systems, were designed to reveal unique cellular activity and functional biological insights critical for research in cancer immunology, cell and gene therapy, inflammation, and neurology. In March 2023, IsoPlexis was acquired by Berkeley Lights, which subsequently rebranded as PhenomeX. PhenomeX, along with the IsoPlexis technology portfolio, was then acquired by Bruker Corporation in late 2023. IsoPlexis's innovative technology continues to contribute to advancements in cellular analysis under Bruker's ownership.
Where Is IsoPlexis's Headquarters?
HQ Function
This facility was the nerve center for IsoPlexis, housing its core research and development activities, manufacturing of its proteomic analysis instruments and reagent kits, and all corporate administrative functions.
Notable Features:
The headquarters was equipped with specialized laboratory spaces for advanced biological research, engineering workshops for instrument prototyping and assembly, and likely cleanroom environments essential for producing sensitive biotech consumables. Specific architectural highlights are not publicly detailed, but functionality for life science operations was paramount.
Work Culture:
The work culture at IsoPlexis's Branford HQ was likely characterized by a dynamic, mission-driven, and collaborative atmosphere, typical of innovative biotech firms. Employees were focused on cutting-edge scientific challenges and translating research into impactful products for the life sciences industry.
HQ Significance:
Branford served as the birthplace and operational hub for IsoPlexis's pioneering single-cell proteomic technologies, including the development and launch of its flagship IsoLight and IsoSpark systems. Its location within a biotech cluster provided access to talent and collaborative opportunities.
Values Reflected in HQ: The headquarters would have embodied IsoPlexis's core values of scientific innovation, precision, and a commitment to advancing human health by enabling deeper biological insights for researchers and therapeutic developers.
Location:
Prior to its acquisition, IsoPlexis Inc. established a global presence, supporting its customer base across North America, Europe, and Asia-Pacific. This was achieved through a network of direct sales teams, field application specialists, and service engineers. The company's operations were focused on delivering its advanced single-cell analysis instruments, consumable kits, and software solutions to academic research institutions, biopharmaceutical companies, and contract research organizations worldwide. This global reach was instrumental in driving the adoption of its technology for applications in immunotherapy, cell and gene therapy, inflammation research, and neurology.
Street Address:
35 NE Industrial Rd
City:
Branford
State/Province:
Connecticut
Country:
USA
Where Else Does IsoPlexis Operate Around the World?
Shanghai, China
Address: [Specific street address not readily available, typically located in a major business or technology park catering to life sciences.]
To expand IsoPlexis's market presence in Asia, provide localized technical expertise and support, and facilitate collaborations with research institutions and biopharmaceutical companies in China and surrounding countries.
Buying Intent Signals for IsoPlexis
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading IsoPlexis? Meet the Executive Team
As of April 2025, IsoPlexis' leadership includes:
Who's Investing in IsoPlexis?
IsoPlexis has been backed by several prominent investors over the years, including:
What Leadership Changes Has IsoPlexis Seen Recently?
IsoPlexis Inc. was acquired by Berkeley Lights (later PhenomeX) in March 2023, and PhenomeX was subsequently acquired by Bruker in late 2023. Consequently, executive movements for the independent 'IsoPlexis Inc.' entity did not occur in the last 12 months as the company was absorbed. Major leadership transitions occurred surrounding these acquisitions.
What Technology (Tech Stack) Is Used byIsoPlexis?
Discover the tools IsoPlexis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
IsoPlexis Email Formats and Examples
Historically, IsoPlexis Inc. likely utilized common corporate email address structures. The primary domain was @isoplexis.com. Given the company's acquisition, these email formats are no longer active for 'IsoPlexis Inc.' as an independent entity.
Common historical formats included [first_initial][last]@isoplexis.com (e.g., jsmith@isoplexis.com) and [first].[last]@isoplexis.com (e.g., john.smith@isoplexis.com).
Format
jsmith@isoplexis.com
Example
75 (estimated historical likelihood of one of these formats being correct for IsoPlexis Inc. prior to acquisition; current deliverability to @isoplexis.com addresses for former personnel is effectively 0).%
Success rate
What's the Latest News About IsoPlexis?
GlobeNewswire • March 1, 2023
Berkeley Lights Completes Acquisition of IsoPlexis, Creating a Premier Functional Cell Biology Company
Berkeley Lights, Inc. (Nasdaq: BLI) announced the successful completion of its acquisition of IsoPlexis Corporation (Nasdaq: ISO). The merger aimed to combine two leading platforms in functional cell biology to create a comprehensive offering for cell-based product development and research. Berkeley Lights subsequently rebranded to PhenomeX....more
Bruker Corporation Press Release • October 2, 2023
Bruker Corporation Successfully Completes Acquisition of PhenomeX
Bruker Corporation (Nasdaq: BRKR) announced the successful completion of its acquisition of PhenomeX (Nasdaq: CELL), formerly Berkeley Lights. This acquisition includes the IsoPlexis single-cell proteomics technology, significantly enhancing Bruker's portfolio and capabilities in life science research and cellular analysis....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including IsoPlexis, are just a search away.